Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants

Seattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants

Jesse Salk, CEO and Co-Founder of TwinStrand Biosciences. (TwinStrand photo) New financing: Gene sequencing startup TwinStrand Biosciences raised $ 50 million in a Series B round led by Section 32, …

Read moreSeattle startup TwinStrand raises $50M to expand tech that identifies rare genetic mutants